Traditional vs Oral Fluid Management in Total Knee Arthroplasty

Overview

Purpose: Evidence-based guidelines on optimal perioperative fluid management have not been established in patients undergoing orthopaedic surgery. Recent randomized trials in major abdominal surgery suggest that large amounts of IV fluid may increase morbidity and hospital stay. This study will investigate the effects of two regimens of intraoperative fluid management ("traditional" vs. "oral") with physiologic and patient function as primary outcome measures after surgery.

Full Title of Study: “Traditional Intravenous Versus Oral Fluid Management in Total Knee Arthroplasty”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: September 10, 2018

Detailed Description

Evidence-based guidelines on optimal perioperative fluid management have not been established in patients undergoing orthopaedic surgery. Typical intraoperative and post-operative fluid management has been arbitrary without evidence based guidelines established following total joint replacement. The investigators have observed many patients post-operatively with side effects such as fluid overload leading to medical complications requiring either prolonged hospitalization or readmission. Additionally, this overload may lead to wound healing complications secondary to fluid shifts which may be devastating in this patient population. Recent randomized trials in major abdominal surgery suggest that large amounts of IV fluid may increase morbidity and hospital stay. Additionally, this increase fluid may be detrimental in patients with anastomosis leading to failure and/or complications in this patient population. The investigators have defined to specific groups of interest to study in this patient population with regards to fluid management. The first group is the "traditional" IV fluid group where the anesthesiologist gives an unspecific amount of fluid intraoperatively and post-operatively the patient gets a set amount of fluid based on "protocol" on the orthopaedic floor (i.e. 75 cc/hour until good oral intake). This is the protocol utilized by most orthopaedic practices throughout the United States. The second group is defined as patients who are given a specific protocol preoperatively to optimize hydration, followed by limited fluids intraoperatively based on physiologic parameters. This study will investigate the effects of two regimens of intraoperative fluid management ("traditional" vs. "oral") with

Interventions

  • Other: Pre Operative Oral Fluids
    • Patients will be self hydrating prior to their total knee replacement.

Arms, Groups and Cohorts

  • No Intervention: Traditional Fluid
    • NPO Clears and Food after midnight. 2 Liters of lactated ringers administered by anesthesia intraoperatively. Postoperatively – 2 Liters of Crystalloid while in PACU and Inpatient Room for a Total of 4 Liters of Crystalloid within 24 hours. (Patient will receive 500 milliliters while in PACU and 1500 milliliters while in their Inpatient Room, for a total of 2 Liters). Normal diet postoperatively.
  • Experimental: Oral Fluid
    • Pre Operative Oral Fluids (Patients encouraged to drink a minimum of 60 ounces of clear liquid per day for the 3 days prior to procedure.) NPO Food/Milk: none beginning 8 hours prior to procedure time. Pre Operative Oral Fluids (Patients are asked to drink 10 ounces of clear liquid 4 hours prior to their scheduled procedure time.) Preoperative holding area, IV is started in the patient with Lactated Ringers IV fluid at a rate of 75ml/hr. IV fluids will be stopped and hep-locked in the PACU when the patient is taking PO fluid; the total amount of IV fluids is not to exceed 500ml total. PO fluid protocol: a minimum of 60 ounces of liquid per day for 3 days.

Clinical Trial Outcome Measures

Primary Measures

  • Body Weight
    • Time Frame: Change is patients weight from baseline at pre op to two weeks post op.
    • Patient Weight will be monitored

Secondary Measures

  • Knee Range of Motion
    • Time Frame: Post Op Day 1, 2 Weeks and 6 Weeks Post Op
    • Measurements will be done with a standard goniometer (Measurements below are shown as the difference from their pre operative base line measurement to the time points below)
  • Leg Anthropometric (Girth) Measurements
    • Time Frame: Post op Day 1, 2 weeks and 6 weeks Post Op
    • measurements will be performed at 5 & 10 cm suprapatellar, midpatella, and 10 cm infrapatellar with the use of a standard tape measure. measurements below show the difference from their pre operative base line measurement to the timepoints below.
  • Number of Participants With Requiring Transfusions
    • Time Frame: intra operative, Post Op Day #1 or #2
    • Post Operative/Intra Operative Transfusions
  • Number of Participants With Off Wound Complications Post Operative
    • Time Frame: Up to 6 weeks Post OP
    • incidence of wound infection and wound drainage will be assessed and recorded
  • Number of Participants With Thromboembolic Disease
    • Time Frame: Post Opeartive until the 6 week follow up appointment
    • The incidence of thromboembolic events will be recorded.
  • Quadriceps Strength Measure With a Handheld Dynamometer
    • Time Frame: Post Op day 1, 2 Week and 6 Week Post OP
    • The strength testing will be calculated using a handheld dynamometer
  • Time up and GO
    • Time Frame: preoperative appointment and once again at their 2 and 6 weeks postoperatively
    • timed up and go (TUG)
  • 30 Second STS Test
    • Time Frame: preoperative appointment and once again at their 2 and 6 weeks postoperatively
    • 30 second sit-to-stand tests
  • Length of the Hospitalization
    • Time Frame: Daily up to 2 days while hospitalized
    • Length of time the patient is Hospitalized after their total knee replacement.
  • Number of Patients Re-admitted Post TKA
    • Time Frame: up to 6 weeks post op
    • Number of patients re-admitted post TKA
  • Postoperative Pain Assessment Using Visual Analog Scale
    • Time Frame: Every 4 hours, averaged daily, reported at Post op day 1 and 2 (while in the hospital), weeks 1, 2, 3, and 4 (3 times a day)
    • Pain will be assessed using a pain Visual Analog scale(VAS), the scale is from 1 to 10, the higher the score the worse the pain.
  • PONV (Post-operative Nausea and Vomiting)
    • Time Frame: Daily up to 2 days while hospitalized
    • patients will be asked about Nausea: None, Mild, Moderate or Severe
  • Veterans Rand -12
    • Time Frame: 2 week and 6 week follow up appointments
    • Patient Reported Outcomes- Veterans Rand(VR-12), there is an algorithm to calculate this score, not a specific range. The higher the number the more positive the output. The score has two components a mental score (MCS) and Physical Score (PCS). Higher values represent a better outcome. MCS Scale 35.089613 to 46.341715 PCS Scale 14.957554 to 63.235672
  • Patient Reported Outcomes – Knee Injury and Osteoarthritis Outcome Score (KOOS)
    • Time Frame: pre-operatively as well as at their 2 week and 6 week follow up appointments
    • Knee injury and Osteoarthritis Outcome Score (KOOS), the scale is 0 to 100, 100 being the best score possible.
  • Patient Reported Outcomes – Knee Society Score(KSS)
    • Time Frame: pre-operatively as well as at their 2 week and 6 week follow up appointments
    • Knee Society Score(KSS), the total scores range from 0 – 200, 200 being the best.
  • Total IV Fluids Received
    • Time Frame: Duration of IV intervention, up to 2 days
    • Total amount of IV fluids that the patients received while in the hospital
  • Bioimpedence
    • Time Frame: pre-op visit, Post Op Day #1 as well as their 2 week and 6 week visit
    • body composition before and after surgery to measure swelling. Lower numbers represent more swelling.

Participating in This Clinical Trial

Inclusion Criteria

• Patients between the ages of 18-75 years old undergoing a primary total knee arthroplasty for a diagnosis of degenerative osteoarthritis who do not meet the exclusion criteria listed below Exclusion Criteria:

  • Volume-dependent cardiac conditions: – Aortic stenosis – Pulmonary valve stenosis – Subaortic stenosis – Severe Aortic Insufficiency – Chronic systolic heart failure – Eisenmeinger Syndrome – Severe pulmonary HTN – Chronic or paroxysmal dysrhythmias – Pre-operative electrolyte abnormalities – Abnormalities of the HPA (hypothalamic-pituitary axis) – Stage 3 Chronic Kidney Disease (or worse) – Patients taking angiotensin receptor blockers (ARB) – Patients with uncontrolled diabetes mellitus (patient with A1C of 7+ or on insulin) – Patients whose BMI is > 35 38 or < 19 – Current use of long acting narcotic medication or 3 or more months of daily short acting narcotic medication – Patients at risk for electrolyte abnormalities, dehydration or intra-operative hypotension. (patients taking angiotensin receptor blockers, ACE inhibitors (48 hours prior to surgery) and Diuretics) – Patients with severe, untreated or uncontrolled GERD. – Patients that cannot receive spinal anesthesia (e.g. patient with back fusions) – Pre-Operative Anemia

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 75 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Colorado Joint Replacement
  • Provider of Information About this Clinical Study
    • Principal Investigator: Jason Jennings, Principal Investigator – Colorado Joint Replacement
  • Overall Official(s)
    • Jason Jennings, MD, Principal Investigator, Colorado Joint Replacement

References

Marjanovic G, Villain C, Juettner E, zur Hausen A, Hoeppner J, Hopt UT, Drognitz O, Obermaier R. Impact of different crystalloid volume regimes on intestinal anastomotic stability. Ann Surg. 2009 Feb;249(2):181-5. doi: 10.1097/SLA.0b013e31818b73dc.

Marjanovic G, Villain C, Timme S, zur Hausen A, Hoeppner J, Makowiec F, Holzner P, Hopt UT, Obermaier R. Colloid vs. crystalloid infusions in gastrointestinal surgery and their different impact on the healing of intestinal anastomoses. Int J Colorectal Dis. 2010 Apr;25(4):491-8. doi: 10.1007/s00384-009-0854-4. Epub 2009 Nov 27.

Kulemann B, Timme S, Seifert G, Holzner PA, Glatz T, Sick O, Chikhladze S, Bronsert P, Hoeppner J, Werner M, Hopt UT, Marjanovic G. Intraoperative crystalloid overload leads to substantial inflammatory infiltration of intestinal anastomoses-a histomorphological analysis. Surgery. 2013 Sep;154(3):596-603. doi: 10.1016/j.surg.2013.04.010. Epub 2013 Jul 19.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.